Physiomics (RVW1) AI Stock Analysis

Physiomics

(Frankfurt:RVW1)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Specialist computational modelling offeringThe company provides specialist systems biology and pharmacology modelling rather than undifferentiated services. This technical focus can support durable client value by helping drug developers interpret data, understand disease mechanisms, and predict drug behaviour.

Negative Factors

Persistent unprofitable operationsThe business has not demonstrated that revenue covers direct and operating costs, with losses persisting across the reported period. Continued negative profitability weakens internally generated capital, limits self-funded growth, and raises pressure to secure further funding.

Physiomics (RVW1) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap: EUR 1.43M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -2.1
Beta (1Y): 1.73
Revenue Growth: 16.13%
EPS Growth: -9.52%
Country: Germany
Employees: 11
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Physiomics Business Overview & Revenue Model

Company Description

Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert consulting services to pharmaceutical enterprises across the United Kingdom, the United States, and the European Union. The company's core specialization lies in outsourced...

Physiomics Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:RVW1 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GB:IXI	55Neutral	GBP 25.73M	-7.14	-16.18%	―	13.04%	15.88%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
GB:TCF	42Neutral	GBP 4.64M	-1.70	-93.92%	―	―	55.56%
GB:VAL	42Neutral	GBP 2.24M	-0.89	-71.49%	―	-34.36%	57.45%
GB:OPTI	41Neutral	GBP 5.99M	-1.40	-77.85%	―	11.90%	-2864.29%
GB:OBD	40Underperform	GBP 14.45M	-0.26	-451.74%	―	33.37%	86.41%

* Healthcare Sector Average

Performance Comparison

DE:RVW1 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:RVW1	Physiomics plc	―	―	―
GB:TCF	Evgen Pharma	0.17	-0.04	-19.05%
GB:IXI	IXICO plc	14.00	2.75	24.44%
GB:OPTI	OptiBiotix Health	5.80	-1.95	-25.16%
GB:OBD	Oxford BioDynamics	0.10	-0.22	-68.13%
GB:VAL	ValiRx plc	0.17	-0.07	-29.17%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Physiomics AI Stock Analysis